United Therapeutics (UTHR) Intangibles (2011 - 2020)

United Therapeutics has disclosed Intangibles across 10 years of filings, most recently posting $128.9 million for Q1 2020.

• Intangibles for Q1 2020 came in at $128.9 million, down 6.39% year-over-year; the trailing twelve-month figure through Mar 2020 was $128.9 million (down 6.39% YoY), and the FY2019 annual result was $128.9 million, down 6.39% from the prior year.
• Intangibles came in at $128.9 million for Q1 2020 at United Therapeutics, roughly flat from $128.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $137.7 million in Q3 2018 to a low of $300000.0 in Q4 2016.
• The 5-year median for Intangibles is $21.5 million (2016), against an average of $53.4 million.
• Across the five-year window, Intangibles soared 9080.0% in 2018 and plunged 98.91% in 2019, its largest moves.
• United Therapeutics' Intangibles stood at $300000.0 in 2016, then jumped by 400.0% to $1.5 million in 2017, then jumped by 9080.0% to $137.7 million in 2018, then declined by 6.39% to $128.9 million in 2019, then changed by 0.0% to $128.9 million in 2020.
• The last three Intangibles figures came in at $128.9 million (Q1 2020), $128.9 million (Q4 2019), and $1.5 million (Q3 2019), per Business Quant data.